
Elucidating how chemotherapy induces neurotoxicity
As a child, Andre Nussenzweig did everything he could to avoid going into science. Both his parents were scientists, and so were many of his relatives. He really wanted to do something different, and his favorite activity was basketball.
“I’m still obsessed with the sports,” Nussenzweig said. “But then I realized that becoming a professional basketball player wasn’t in the cards, so I should find something else.”

Nussenzweig explored philosophy, business and the social sciences before deciding to major in physics in college. He trained as a physicist in his Ph.D. program at Yale, and then in his first postdoctoral fellowship in Paris.
“Science is more me,” he said. “But it still has a competitive edge, so in a way there are some interesting parallels with sports.”
Nussenzweig said he found it challenging to make advances in physics because so much was already known. In biology, however, scientists’ predictions often don’t come true. And while unexpected results are sometimes disappointing, they make room for new discoveries.
“Physics didn’t have the same excitement that I saw in biology,” he said.
At first, Nussenzweig considered switching to structural biology. Many physicists who wanted to transition into biology chose this path, he said, because there are some overlaps between the two.
But, the plan didn’t end up working for him. He started taking courses in molecular biology and really enjoyed it. So, he did another postdoctoral fellowship at Memorial Sloan–Kettering Cancer Center for some hands-on experience, then joined the National Institutes of Health in 1998 where he started his own lab.
“The key thing is to be really honest with yourself, see what you enjoy and be fearless about pursuing it, whatever it is,” Nussenzweig said.
“Even if your background and your training aren’t great fits for the role,” he added. “Because you’ll just learn it as you go.”
Nussenzweig will receive the 2025 Bert and Natalie Vallee Award in Biomedical Science, which the 91ÑÇÉ«´«Ã½ presents to an established scientist for outstanding accomplishments in basic biomedical research. His lab studies how DNA damage arises in cancer, as well as in noncancerous, nondividing cells such as neurons.
A detour from heat-shock to DNA repair
Andre Nussenzweig stumbled on the study of DNA damage and repair serendipitously during his postdoc at Sloan-Kettering when his team was working on a project they thought was related to heat-shock proteins. Nussenzweig had generated a knockout mouse for a protein he believed was implicated in the heat-shock response.
“It turned out that gene had nothing to do with heat-shock,” he said. “Instead, it was involved in DNA repair.”Nussenzweig also studies chemotherapies, which purposely induce DNA damage. Specifically, his lab has been looking into the neurotoxic side effects. Although chemotherapy is constantly improving, he said, patients often end up with persistent neurological symptoms and cognitive impairment. Nussenzweig’s team is interested in understanding how different kinds of chemotherapy cause neuron loss or toxicity and how to prevent it.
“This is a really big problem in the field,” he said, “and not many people have worked on understanding mechanisms by which chemotherapy induces neurotoxicity.”
Andre Nussenzweig will present a talk titled “Maintaining genome stability” at the 2025 91ÑÇÉ«´«Ã½ Annual Meeting, April 12–15 in Chicago.
91ÑÇÉ«´«Ã½ 2025 award winners
Read profiles of all the society’s 2025 honorees who will receive their awards and give talks at the 91ÑÇÉ«´«Ã½ Annual Meeting, April 12–15 in Chicago.
From receptor research to cancer drug development: The impact of RTKs
Joseph Schlessinger receives the 91ÑÇÉ«´«Ã½ Herbert Tabor Research Award.
Computational and biophysical approaches to disordered proteins
Rohit Pappu receives the DeLano Award for Computational Biosciences.
Leading the charge for gender equity
Nicole Woitowich receives the 91ÑÇÉ«´«Ã½ Emerging Leadership Award.
Helping underrepresented scientists feel seen
Benjamin Garcia receives the 91ÑÇÉ«´«Ã½ Ruth Kirschstein Diversity in Science Award.
Transforming learning through innovation and collaboration
Neena Grover receives the William C. Rose Award for Exemplary Contributions to Education.
Curiosity turned a dietitian into a lipid scientist
Judy Storch receives the Avanti Award in Lipids.
Elucidating how chemotherapy induces neurotoxicity
Andre Nussenzweig receives the Bert and Natalie Vallee Award.
What seems dead may not be dead
Vincent Tagliabracci receives the Earl and Thressa Stadtman Distinguished Scientist Award.
'You can't afford to be 15 years behind the parasite'
David Fidock receives the Alice and C.C. Wang Award in Molecular Parasitology.
Guiding grocery carts to shape healthy habits
Robert Helsley receives the Walter A. Shaw Young Investigator in Lipid Research Award.
Enjoy reading 91ÑÇÉ«´«Ã½ Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from 91ÑÇÉ«´«Ã½ Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

Hidden strengths of an autistic scientist
Navigating the world of scientific research as an autistic scientist comes with unique challenges —microaggressions, communication hurdles and the constant pressure to conform to social norms, postbaccalaureate student Taylor Stolberg writes.

Richard Silverman to speak at 91ÑÇÉ«´«Ã½ 2025
Richard Silverman and Melissa Moore are the featured speakers at the 91ÑÇÉ«´«Ã½ annual meeting to be held April 12-15 in Chicago.

Women’s History Month: Educating and inspiring generations
Through early classroom experiences, undergraduate education and advanced research training, women leaders are shaping a more inclusive and supportive scientific community.

91ÑÇÉ«´«Ã½ honors Lawrence Tabak with public service award
He will deliver prerecorded remarks at the 2025 91ÑÇÉ«´«Ã½ Annual Meeting in Chicago.

91ÑÇÉ«´«Ã½ names 2025 JBC/Tabor Award winners
The six awardees are first authors of outstanding papers published in 2024 in the Journal of Biological Chemistry.

Daniel N. Hebert (1962–2024)
Daniel Hebert’s colleagues remember the passionate glycobiologistscientist, caring mentor and kind friend.